May 31, 2023 – The $42 million being allocated for ibogaine research is coming from Kentucky’s Opioid Settlement Fund. This fund was developed following a 2022 nationwide agreement with major pharmaceutical distributors and marketers of opioids to distribute $26 billion to populations affected by opioid addiction. Kentucky was allocated $478 million from this agreement — 50% of which goes to local government, and 50 percent of which is to be received by “the Commonwealth.” Funds allocated to Kentucky increased to over $842 million earlier this year. The commonwealth’s portion is managed by the Kentucky Opioid Abatement Advisory Committee , the organization which announced that $42 million will be invested in ibogaine research.
TOO LITTLE, TOO LATE? – Dec. 19, 2024 - Assembly Bill 56 (AB 56) proposes…
AND STOPPED DIGGING – Dec. 4, 2024 - In a new interview with The Times,…
NOT JUST IN PENCILS – Dec. 8, 2024 - Americans born before 1966 experienced “significantly…
AS SUCCESSFUL AS EVER – Dec. 3, 2024 - Family Affair actor Johnny Whitaker looked…
ALANON Plus – Dec. 7, 2024 - A high percentage of treatment failures occur due…
AUDIO – A GIANT IS GONE – Dec. 10, 2024 - Nikki Giovanni, the poet,…